• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高效液相色谱法测定人血浆中柔红霉素和柔红霉醇的含量。

HPLC determination of daunorubicin and daunorubicinol in human plasma.

作者信息

Hulhoven R, Desager J P

出版信息

Biomedicine. 1977 Apr;27(3):102-4.

PMID:890014
Abstract

A high-performance liquid chromatographic method for the quantitative simultaneous measurement of daunorubicin and its active metabolite, daunorubicinol, at low concentrations in human plasma was described. The advantages of this method were specificity, sensitivity, minimal pre-analysis work-up and small sample size. The method was sensitive for plasma levels of daunorubicin and daunorubicinol as low as 10 ng/ml. Preliminary dosages on plasma from leukemic patients treated with a 4 hr infusion of 75 mg/m2 daunorubicin either as free drug or complexed with DNA were reported. The results suggested a slower disposition of the daunorubicin-DNA complex.

摘要

描述了一种高效液相色谱法,用于在人血浆中低浓度下同时定量测定柔红霉素及其活性代谢物柔红霉醇。该方法的优点是特异性、灵敏度、最小的分析前处理和小样本量。该方法对血浆中低至10 ng/ml的柔红霉素和柔红霉醇水平敏感。报告了对白血病患者血浆的初步剂量测定结果,这些患者接受了4小时输注75 mg/m2柔红霉素,药物形式为游离药物或与DNA复合。结果表明柔红霉素-DNA复合物的处置较慢。

相似文献

1
HPLC determination of daunorubicin and daunorubicinol in human plasma.高效液相色谱法测定人血浆中柔红霉素和柔红霉醇的含量。
Biomedicine. 1977 Apr;27(3):102-4.
2
Daunorubicin, daunorubicinol and DNA plasma kinetics after I.V. administration of daunorubican-DNA complex in the rabbit.静脉注射柔红霉素 - DNA复合物后家兔体内柔红霉素、柔红霉素醇及DNA的血浆动力学
Biomedicine. 1978 Jul;29(5):164-7.
3
Facile and definitive determination of human adriamycin and daunoribicin metabolites by high-pressure liquid chromatography.通过高压液相色谱法简便、准确地测定人阿霉素和柔红霉素代谢物
Drug Metab Dispos. 1980 May-Jun;8(3):152-6.
4
Liquid chromatographic determination of daunorubicin and daunorubicinol in plasma from leukemic patients.白血病患者血浆中柔红霉素和柔红霉醇的液相色谱测定法
J Chromatogr. 1978 Jun 1;153(1):211-8. doi: 10.1016/s0021-9673(00)89874-x.
5
Liquid chromatographic monitoring of daunorubicin and daunorubicinol in plasma from leukemic patients treated with daunorubicin or the daunorubicin-DNA complex.对接受柔红霉素或柔红霉素-DNA复合物治疗的白血病患者血浆中柔红霉素和柔红霉素醇的液相色谱监测。
Cancer Chemother Pharmacol. 1979;2(1):15-7. doi: 10.1007/BF00253099.
6
Simultaneous determination of cytosine arabinoside, daunorubicin and etoposide in human plasma.同时测定人血浆中的阿糖胞苷、柔红霉素和依托泊苷。
J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Jul 15;878(22):1967-72. doi: 10.1016/j.jchromb.2010.05.031. Epub 2010 May 31.
7
High performance liquid chromatography determination of doxorubicin and daunorubicin in plasma using UV detection and column switching.
Biomed Chromatogr. 1990 Jul;4(4):154-6. doi: 10.1002/bmc.1130040408.
8
Doxorubicin and daunorubicin plasmatic, hepatic and renal disposition in the rabbit with or without enterohepatic circulation.多柔比星和柔红霉素在有或无肠肝循环的兔体内的血浆、肝脏和肾脏分布情况。
J Pharmacol. 1986 Jan-Mar;17(1):1-13.
9
Phase 1 trial and assay of rubidazone (NSC 164011) in patients with advanced solid tumors.
Cancer Res. 1979 Mar;39(3):823-8.
10
Leukemic cell versus plasma levels of daunorubicin and daunorubicinol after infusion of daunorubicin as free drug or the DNA complex.
Cancer Chemother Pharmacol. 1980;4(3):205-7. doi: 10.1007/BF00254020.

引用本文的文献

1
Evaluation of Pt,Pd-Doped, NiO-Decorated, Single-Wall Carbon Nanotube-Ionic Liquid Carbon Paste Chemically Modified Electrode: An Ultrasensitive Anticancer Drug Sensor for the Determination of Daunorubicin in the Presence of Tamoxifen.铂、钯掺杂、氧化镍修饰的单壁碳纳米管-离子液体碳糊化学修饰电极的评估:一种用于在他莫昔芬存在下测定柔红霉素的超灵敏抗癌药物传感器。
Front Chem. 2020 Aug 19;8:677. doi: 10.3389/fchem.2020.00677. eCollection 2020.
2
Pharmacokinetics of daunorubicin after administration as free drug or as DNA complex in leukemic patients.白血病患者接受游离柔红霉素或柔红霉素与DNA复合物给药后的药代动力学。
Cancer Chemother Pharmacol. 1981;5(4):261-6. doi: 10.1007/BF00434395.
3
Daunorubicin-DNA complex in acute nonlymphoblastic leukemia.
柔红霉素-DNA复合物与急性非淋巴细胞白血病
Cancer Chemother Pharmacol. 1982;8(3):318. doi: 10.1007/BF00254059.
4
Anthracycline antitumour agents. A review of physicochemical, analytical and stability properties.蒽环类抗肿瘤药物。物理化学、分析及稳定性性质综述。
Pharm Weekbl Sci. 1986 Apr 25;8(2):109-33. doi: 10.1007/BF02086146.
5
Human pharmacokinetics of the daunorubicin-DNA complex. An alternative view of the lysosomotropic theory.
Cancer Chemother Pharmacol. 1979;3(4):243-7. doi: 10.1007/BF00254739.
6
Clinical trials with daunorubicin-DNA and adriamycin-DNA in acute lymphoblastic leukemia of childhood, acute nonlymphoblastic leukemia, and bronchogenic carcinoma.柔红霉素-DNA和阿霉素-DNA用于儿童急性淋巴细胞白血病、急性非淋巴细胞白血病及支气管癌的临床试验。
Cancer Chemother Pharmacol. 1979;2(1):67-71. doi: 10.1007/BF00253108.